Arbutus Biopharma Corp (NASDAQ:ABUS)
| 3.93 Delayed Data As of Dec 03 |  -0.01 / -0.25%Today’s Change | 0.88 Today|||52-Week Range 9.02 | +41.37% Year-to-Date |
Latest ABUS News | Press Releases
No recent news for Arbutus Biopharma Corp.
Today’s Trading
| Previous close | 3.95 |
| Today’s open | 4.03 |
| Day’s range | 3.91 - 4.09 |
| Volume | 2,122,774 |
| Average volume (3 months) | 2,856,854 |
| Market cap | $368.5M |
Data as of 3:59pm ET, 12/03/2020
Growth & Valuation
| Earnings growth (last year) | -137.84% |
| Earnings growth (this year) | +66.23% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +1.11% |
| P/E ratio | NM |
| Price/Sales | 26.40 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CTMXCytomX Therapeutics ... | -0.15 | -2.02% |
| GMDAGamida Cell Ltd | -0.19 | -2.80% |
| FULCFulcrum Therapeutics... | +0.11 | +0.94% |
| CNCEConcert Pharmaceutic... | -0.59 | -5.28% |
Data as of 3:59pm ET, 12/03/2020
Financials
| Next reporting date | March 11, 2021 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $6.0M |
| Annual profit (last year) | -$153.7M |
| Net profit margin | -2,557.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Warminster, Pennsylvania |
Forecasts
